Back to top

Guardant Health: Buy Rating Reaffirmed as UnitedHealth Coverage Expands Shield Access; 12-Month Price Target Maintained at $165

Guardant Health, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Evie Koslosky from Goldman Sachs maintain...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Guardant Health, Inc. (GH)